Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia. [electronic resource]
Producer: 20160229Description: 6448-58 p. digitalISSN:- 1949-2553
- Aclarubicin -- administration & dosage
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Azacitidine -- administration & dosage
- Cytarabine -- administration & dosage
- Decitabine
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Prospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.